Oneness Biotech Co., Ltd. (4743.TWO)

151,00 +2,00 (+1,34%) Ab 10:22AM CST. Markt geöffnet.

Oneness Biotech Co., Ltd.

No.236, Xinyi Road
11th Floor Sec. 4 Da’an district
Taipei 106
Taiwan
886 2 2703 1098
https://www.onenessbio.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Nien-Yi Chen	Deputy General Manager of Antibody New Drug Division;	6,03M	N/A	N/A
Ms. Shuling Cheng Ph.D.	President	N/A	N/A	N/A
Ms. Wen-Tzu Hsiao	Acting Spokesperson & Senior Manager of Finance Department	N/A	N/A	N/A
Wen Ci Xiao	Accounting Supervisor	N/A	N/A	N/A
Dr. Jui-Ching Chen Ph.D.	Director of New Drug Development Department	N/A	N/A	N/A
Mr. Kung-Ming Lu	Director of Operation Center	N/A	N/A	N/A
Mr. Tzu-Chun Yang	Associate General Manager of Information Technology Department	2,14M	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in TWD.

Beschreibung

Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB825, which is in Phase IIa clinical trial for treating atopic dermatitis and allergic asthma; FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis; OB318, an anticancer botanical drug of antrodia cinnamomea; SNS812, for the treatment of COVID-19 that is in Phase I clinical trials; and FB918 for the treatment of asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and production and sale of agricultural products. Oneness Biotech Co., Ltd. was incorporated in 2008 and is headquartered in Taipei, Taiwan.

Corporate Governance

Oneness Biotech Co., Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.